Replies to post #153266 on Cytodyn Inc (CYDY)

[3X Charm]

Look back over time as to who was on the BOD when the HIV trial was completed. Several pharma
BOD members are no longer with the company due to the personal liability NP created due to lack of detail and loose promises.

[Twister]

Incomplete/omission of material information needs regulatory scrutiny!

Unfortunately, the Board of Directors have failed taking necessary immediate corrective actions, thereby allowing these actions to continue.

This deficient pattern regarding releasing material information must be addressed and corrected, seemingly now by securities regulators.
Given ongoing lapses, perhaps a closer look into other Corporate actions/inactions will also become prudent or even necessary.

As a shareholder, I fear these problems/issues beyond that of any drug acceptance, approval delays or even failures.

[Learning53]

Blue man - agree!
I posted in the "wee hours" about roughly the same topic...Cytodyn's need for a skilled PR person

[C-20]

BlueMan- that’s exactly the way I see it. They need a PR team